To examine the effect of p53 inhibition on the growth of MDS/AML cells, we transduced Cas9 and Trp53-targeting sgRNAs into cSAM and cRAM cells (Fig. 3a). This evidence concerns the gene TP53 and myelodysplastic syndrome.